1. 23.2 ALPHA 7 NICOTINIC MODULATORS REVERSE THE HYPERDOPAMINERGIC TONE IN THE MAM MODEL OF SCHIZOPHRENIA. (9th April 2019) Authors: Grace, Anthony; Neves, Gilda Journal: Schizophrenia bulletin Issue: Volume 45(2019)Supplement 2 Page Start: S126 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Blockade of cannabinoid type 2 receptor inhibits a working memory impairment relevant for schizophrenia. (September 2019) Authors: Nunes, Luis Eduardo; Neves, Gilda; Castro, Newton; Andrade, Brenda; Cunha, Gisely; Cunha, Nathalia; Lione, Thainá; Nazareth, Nicole; Marques, Adriana; Ferreira, Bruna; Diniz, Fabiola; Ferreira, Gustavo Journal: IBRO reports Issue: Volume 6(2019)Supplement Page Start: S447 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. S232. ALPHA7 NICOTINIC RECEPTOR AGONISTS REVERSE THE HYPERDOPAMINERGIC STATE IN THE MAM MODEL OF SCHIZOPHRENIA. (1st April 2018) Authors: Neves, Gilda; Grace, Anthony Journal: Schizophrenia bulletin Issue: Volume 44(2018)Supplement 1 Page Start: S416 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗